DIPIPERON

Dipiperon Adverse Events Reported to the FDA Over Time

How are Dipiperon adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Dipiperon, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Dipiperon is flagged as the suspect drug causing the adverse event.

Most Common Dipiperon Adverse Events Reported to the FDA

What are the most common Dipiperon adverse events reported to the FDA?

Somnolence	58 (4.79%)
Fall	41 (3.39%)
Suicide Attempt	36 (2.98%)
Drug Interaction	30 (2.48%)
Death	19 (1.57%)
Hyponatraemia	18 (1.49%)
Hypotension	18 (1.49%)
Fatigue	16 (1.32%)
Tachycardia	16 (1.32%)
Intentional Overdose	15 (1.24%)
Vomiting	14 (1.16%)
	Show More
Dehydration	13 (1.07%)
Multiple Drug Overdose Intentional	13 (1.07%)
Drug Exposure During Pregnancy	12 (.99%)
Pregnancy	12 (.99%)
Blood Creatine Phosphokinase Increa...	11 (.91%)
Circulatory Collapse	11 (.91%)
Dyspnoea	11 (.91%)
Disorientation	10 (.83%)
Drug Abuse	10 (.83%)
Respiratory Failure	10 (.83%)
Spina Bifida	10 (.83%)
Bradycardia	9 (.74%)
Convulsion	9 (.74%)
Nausea	9 (.74%)
Restlessness	9 (.74%)
Agitation	8 (.66%)
Alpha 1 Foetoprotein Amniotic Fluid...	8 (.66%)
Cardiac Arrest	8 (.66%)
Electrocardiogram Qt Prolonged	8 (.66%)
Pleurothotonus	8 (.66%)
Diarrhoea	7 (.58%)
Electroencephalogram Abnormal	7 (.58%)
Hypernatraemia	7 (.58%)
Hyperparathyroidism	7 (.58%)
Hyperthyroidism	7 (.58%)
Microcephaly	7 (.58%)
Stevens-johnson Syndrome	7 (.58%)
Syncope	7 (.58%)
Aspartate Aminotransferase Increase...	6 (.5%)
Blood Pressure Decreased	6 (.5%)
Extrapyramidal Disorder	6 (.5%)
Gammopathy	6 (.5%)
General Physical Health Deteriorati...	6 (.5%)
Hypercalcaemia	6 (.5%)
Hyperviscosity Syndrome	6 (.5%)
Malaise	6 (.5%)
Overdose	6 (.5%)
Parkinsonism	6 (.5%)
Pneumonia	6 (.5%)
Urinary Retention	6 (.5%)
Aggression	5 (.41%)
Arrhythmia	5 (.41%)
Asthenia	5 (.41%)
Caesarean Section	5 (.41%)
Coma	5 (.41%)
Delirium	5 (.41%)
Depression	5 (.41%)
Disturbance In Attention	5 (.41%)
Dizziness	5 (.41%)
Grand Mal Convulsion	5 (.41%)
Hallucination	5 (.41%)
Hypokalaemia	5 (.41%)
Hypothermia	5 (.41%)
Panic Attack	5 (.41%)
Pulmonary Embolism	5 (.41%)
Respiratory Distress	5 (.41%)
Rhabdomyolysis	5 (.41%)
Toxic Epidermal Necrolysis	5 (.41%)
Accidental Exposure	4 (.33%)
Adverse Event	4 (.33%)
Akathisia	4 (.33%)
Alanine Aminotransferase Increased	4 (.33%)
Anaemia	4 (.33%)
Angina Pectoris	4 (.33%)
Cerebrovascular Accident	4 (.33%)
Cholestasis	4 (.33%)
Completed Suicide	4 (.33%)
Condition Aggravated	4 (.33%)
Coronary Artery Disease	4 (.33%)
Cyanosis	4 (.33%)
Diet Refusal	4 (.33%)
Gamma-glutamyltransferase Increased	4 (.33%)
Hallucination, Auditory	4 (.33%)
Hallucination, Visual	4 (.33%)
Hyperventilation	4 (.33%)
Hypoglycaemia	4 (.33%)
Inappropriate Schedule Of Drug Admi...	4 (.33%)
Loss Of Consciousness	4 (.33%)
Multiple Drug Overdose	4 (.33%)
Productive Cough	4 (.33%)
Urinary Tract Infection	4 (.33%)
Abdominal Pain Upper	3 (.25%)
Alcohol Poisoning	3 (.25%)
Anxiety	3 (.25%)
Aphthous Stomatitis	3 (.25%)
Arnold-chiari Malformation	3 (.25%)
Atrial Fibrillation	3 (.25%)
Benign Prostatic Hyperplasia	3 (.25%)
Blister	3 (.25%)
C-reactive Protein Increased	3 (.25%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Dipiperon, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Dipiperon is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Dipiperon

What are the most common Dipiperon adverse events reported to the FDA?

Neurological	100 (8.26%)
Cardiac Arrhythmias	57 (4.71%)
Medication Errors	54 (4.46%)
Injuries	44 (3.64%)
Suicidal And Self-injurious Behavio...	44 (3.64%)
Electrolyte And Fluid Balance Condi...	43 (3.55%)
Respiratory	39 (3.22%)
Therapeutic And Nontherapeutic Effe...	37 (3.06%)
Decreased And Nonspecific Blood Pre...	33 (2.73%)
Movement Disorders	33 (2.73%)
Gastrointestinal Signs	30 (2.48%)
	Show More
Epidermal And Dermal Conditions	22 (1.82%)
Fatal Outcomes	22 (1.82%)
Cardiac And Vascular Investigations	21 (1.74%)
Anxiety Disorders	20 (1.65%)
Hepatobiliary	19 (1.57%)
Chemical Injury And Poisoning	18 (1.49%)
Deliria	18 (1.49%)
Seizures	18 (1.49%)
Neurological Disorders Congenital	16 (1.32%)
Hepatic And Hepatobiliary	15 (1.24%)
Disturbances In Thinking	14 (1.16%)
Infections - Pathogen Unspecified	14 (1.16%)
Pregnancy, Labour, Delivery And Pos...	12 (.99%)
Urinary Tract Signs	12 (.99%)
Appetite And General Nutritional	11 (.91%)
Enzyme	11 (.91%)
Hematology Investigations	11 (.91%)
Psychiatric	11 (.91%)
Muscle	10 (.83%)
Changes In Physical Activity	9 (.74%)
Gastrointestinal Motility And Defec...	9 (.74%)
Musculoskeletal And Connective Tiss...	9 (.74%)
Personality Disorders	9 (.74%)
Thyroid Gland	9 (.74%)
Body Temperature Conditions	8 (.66%)
Cardiac Disorder Signs	8 (.66%)
Coronary Artery	8 (.66%)
Fetal And Neonatal	8 (.66%)
Lifestyle Issues	8 (.66%)
Mental Impairment	8 (.66%)
Neurological, Special Senses And Ps...	8 (.66%)
Central Nervous System Vascular	7 (.58%)
Musculoskeletal And Connective Tiss...	7 (.58%)
Oral Soft Tissue Conditions	7 (.58%)
Parathyroid Gland	7 (.58%)
Bone, Calcium, Magnesium And Phosph...	6 (.5%)
Depressed Mood Disorders	6 (.5%)
Hematological	6 (.5%)
Ocular Infections, Irritations And ...	6 (.5%)
Plasma Cell Neoplasms	6 (.5%)
Schizophrenia And Other Psychotic	6 (.5%)
White Blood Cell	6 (.5%)
Obstetric And Gynecological Therape...	5 (.41%)
Protein And Chemistry Analyses	5 (.41%)
Pulmonary Vascular	5 (.41%)
Sleep Disorders	5 (.41%)
Vascular	5 (.41%)
Anemias Nonhemolytic And Marrow Dep...	4 (.33%)
Communication Disorders	4 (.33%)
Exocrine Pancreas Conditions	4 (.33%)
Fetal Complications	4 (.33%)
Glucose Metabolism Disorders	4 (.33%)
Neuromuscular	4 (.33%)
Physical Examination Topics	4 (.33%)
Renal And Urinary Tract Investigati...	4 (.33%)
Renal Disorders	4 (.33%)
Tongue Conditions	4 (.33%)
Water, Electrolyte And Mineral	4 (.33%)
Arteriosclerosis, Stenosis, Vascula...	3 (.25%)
Bone And Joint Injuries	3 (.25%)
Breast	3 (.25%)
Cardiac Valve	3 (.25%)
Embolism And Thrombosis	3 (.25%)
Fungal Infectious	3 (.25%)
Gastrointestinal Stenosis And Obstr...	3 (.25%)
Heart Failures	3 (.25%)
Joint	3 (.25%)
Lower Respiratory Tract Disorders	3 (.25%)
Mood Disorders	3 (.25%)
Musculoskeletal And Soft Tissue Inv...	3 (.25%)
Neonatal And Perinatal Conditions	3 (.25%)
Ocular Neuromuscular	3 (.25%)
Pleural	3 (.25%)
Prostatic Disorders	3 (.25%)
Vascular Hypertensive	3 (.25%)
Vision	3 (.25%)
Acid-base	2 (.17%)
Dental And Gingival Conditions	2 (.17%)
Gastrointestinal Neoplasms Malignan...	2 (.17%)
Inner Ear And Viiith Cranial Nerve	2 (.17%)
Metabolic, Nutritional And Blood Ga...	2 (.17%)
Metastases	2 (.17%)
Myocardial	2 (.17%)
Psychiatric And Behavioural Symptom...	2 (.17%)
Salivary Gland Conditions	2 (.17%)
Skin Vascular Abnormalities	2 (.17%)
Spleen, Lymphatic And Reticulendoth...	2 (.17%)
Therapeutic Procedures And Supporti...	2 (.17%)
Toxicology And Therapeutic Drug Mon...	2 (.17%)
Bacterial Infectious	1 (.08%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Dipiperon, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Dipiperon is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.